 "Piramal Enterprises")
Piramal Enterprises reported on Thursday a consolidated net profit of Rs 151 crore in the January-March quarter of FY22, compared to loss of Rs 510 crore in the year-ago period. The net profit was factored additional provisioning of Rs 822 crore and interest reversal of Rs 215 crore.
Revenues were up 16 per cent year-on-year (YoY) to Rs 4,163 crore in Q4FY22 as against Rs 3,402 crore. For the whole year (FY22), revenues of the company grew 9 per cent to Rs 13,993 crore.
The board of the financial services-to pharmaceuticals conglomerate recommended a dividend of Rs 33 per share, subject to shareholder’s approval.
